Work

SAT0463 Initial Therapy with an Endothelin Receptor Antagonist (ERA) is Associated with Worse Outcomes in Patients with Systemic Sclerosis and Pulmonary Arterial Hypertension: Observations from the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Cohort (Pharos)

Year: 2015

Type: conference-abstract

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2015-eular.2538

Authors: M.R. Lammi, L.A. Saketkoo, S.C. Mathai, R.T. Domsic, V. Steen, D.E. Furst

Institutions: Louisiana State University, Tulane University, Johns Hopkins University, Johns Hopkins Medicine, University of Pittsburgh Medical Center, Georgetown University, University of California, Los Angeles

Language: English

Topic: Pulmonary Hypertension Research and Treatments

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2409452176

Cites:

Cited by:

Related to: 10